Anugerah 88 Logo
$2.07+0.03|(+1.47%)
52W H: 5.1852W L: 1.79Beta: 0.36

About Grace Therapeutics, Inc

Frequently Asked Questions

What is the 52-week range for GRCE?

The 52-week high is $5.18 and the 52-week low is $1.79.

What is the P/E ratio for GRCE?

The P/E ratio data is currently unavailable.

What is the dividend yield for GRCE?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -33.73%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -4435.00%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 1.12.

Analyst Recommendation Trends

Wall Street analyst consensus for GRCE over the last few months:

2026-09-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0

Related Stocks (Peers)

Companies operating in similar sectors to GRCE:

LONAFLNAGRCEVERUBTMDGRCESHRX.VMIRASCLXCNTXIGCLLY

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-29Opaleye Management Inc.+7,849$2.09$16,404
2026-09-23Opaleye Management Inc.+5,318$2.1$11,168
2026-09-23Opaleye Management Inc.+5,318$2.1$11,168
2026-09-21Opaleye Management Inc.+9,771$2.1$20,519
2026-09-21Opaleye Management Inc.+9,771$2.1$20,519
2026-09-17Kavuru Vimal+12,200--
2026-09-17Kottayil George+12,200--
2026-09-17NEUGEBOREN EDWARD+12,200--
2026-09-17DAVIS A BRIAN0--
2026-09-09Opaleye Management Inc.+5,836$2.0899$12,197
2026-09-09Kohli Prashant+100,000$2.14$214,000
2026-09-08Opaleye Management Inc.+9,393$2.0972$19,699
2026-08-28Kohli Prashant+267,160--
2026-08-28Kumar Amresh+35,760--
2026-08-28Macdonald R. Loch+54,690--
2026-08-28DelAversano Robert J+33,660--
2026-08-14Opaleye Management Inc.+11,608$2.0853$24,206
2026-01-08Kavuru Vimal+10,000--
2026-01-08Kottayil George+10,000--
2026-01-08NEUGEBOREN EDWARD+10,000--
2026-01-08DAVIS A BRIAN+10,000--